FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092632935> ?p ?o ?g. }

• W2092632935 endingPage "528" @default.
• W2092632935 startingPage "511" @default.
• W2092632935 abstract "ESRD produces a chronic catabolic state that results in significant skeletal muscle atrophy, weakness, and physical dysfunction. Any intervention that can ameliorate this process can significantly improve quality of life. Some studies have shown that endurance exercise training, even at low intensities, may exhibit anabolic effects and improved physical function. However, resistance exercise training is of primary interest as an anabolic intervention because it is the mode of exercise that is most efficacious in stimulating anabolic responses, improved muscle performance, and physical function. A relatively small number of controlled trials of resistance training in ESRD patients have failed to show significant changes in LBM, although some studies have shown significant improvements in other markers of anabolism. Increases in muscle strength with resistance training are typical but improved physical function, either by objective measurement or self-report, are equivocal. Study durations, loads used during training, and relatively small sample sizes may in part explain the inability of previous studies to observe more substantial changes in LBM and physical function. Androgens and growth hormone have been shown to significantly improve LBM and strength, although longer-term studies for safety and efficacy are necessary before their general recommendation for patients with ESRD. ESRD produces a chronic catabolic state that results in significant skeletal muscle atrophy, weakness, and physical dysfunction. Any intervention that can ameliorate this process can significantly improve quality of life. Some studies have shown that endurance exercise training, even at low intensities, may exhibit anabolic effects and improved physical function. However, resistance exercise training is of primary interest as an anabolic intervention because it is the mode of exercise that is most efficacious in stimulating anabolic responses, improved muscle performance, and physical function. A relatively small number of controlled trials of resistance training in ESRD patients have failed to show significant changes in LBM, although some studies have shown significant improvements in other markers of anabolism. Increases in muscle strength with resistance training are typical but improved physical function, either by objective measurement or self-report, are equivocal. Study durations, loads used during training, and relatively small sample sizes may in part explain the inability of previous studies to observe more substantial changes in LBM and physical function. Androgens and growth hormone have been shown to significantly improve LBM and strength, although longer-term studies for safety and efficacy are necessary before their general recommendation for patients with ESRD." @default.
• W2092632935 created "2016-06-24" @default.
• W2092632935 creator A5068496436 @default.
• W2092632935 date "2009-11-01" @default.
• W2092632935 modified "2023-09-30" @default.
• W2092632935 title "Anabolic Interventions in ESRD" @default.
• W2092632935 cites W1518465361 @default.
• W2092632935 cites W1576728172 @default.
• W2092632935 cites W1593659925 @default.
• W2092632935 cites W1921714027 @default.
• W2092632935 cites W1965619541 @default.
• W2092632935 cites W1965818295 @default.
• W2092632935 cites W1966668312 @default.
• W2092632935 cites W1973621214 @default.
• W2092632935 cites W1974658525 @default.
• W2092632935 cites W1978160551 @default.
• W2092632935 cites W1979747807 @default.
• W2092632935 cites W1982492614 @default.
• W2092632935 cites W1988730062 @default.
• W2092632935 cites W1989853418 @default.
• W2092632935 cites W1993456358 @default.
• W2092632935 cites W2000198481 @default.
• W2092632935 cites W2002568122 @default.
• W2092632935 cites W2003896958 @default.
• W2092632935 cites W2009175015 @default.
• W2092632935 cites W2015557228 @default.
• W2092632935 cites W2019825442 @default.
• W2092632935 cites W2023723955 @default.
• W2092632935 cites W2026065533 @default.
• W2092632935 cites W2027825989 @default.
• W2092632935 cites W2032756850 @default.
• W2092632935 cites W2035385301 @default.
• W2092632935 cites W2037215915 @default.
• W2092632935 cites W2048571843 @default.
• W2092632935 cites W2056866323 @default.
• W2092632935 cites W2085126639 @default.
• W2092632935 cites W2095278718 @default.
• W2092632935 cites W2095471601 @default.
• W2092632935 cites W2101527903 @default.
• W2092632935 cites W2101639603 @default.
• W2092632935 cites W2113153678 @default.
• W2092632935 cites W2114239244 @default.
• W2092632935 cites W2116511383 @default.
• W2092632935 cites W2117789523 @default.
• W2092632935 cites W2119790468 @default.
• W2092632935 cites W2122275658 @default.
• W2092632935 cites W2125502122 @default.
• W2092632935 cites W2133467178 @default.
• W2092632935 cites W2139433747 @default.
• W2092632935 cites W2140056891 @default.
• W2092632935 cites W2144296942 @default.
• W2092632935 cites W2144455139 @default.
• W2092632935 cites W2152200657 @default.
• W2092632935 cites W2154533640 @default.
• W2092632935 cites W2160942344 @default.
• W2092632935 cites W2162184347 @default.
• W2092632935 cites W2166546239 @default.
• W2092632935 cites W2167785130 @default.
• W2092632935 cites W2171923395 @default.
• W2092632935 cites W3143060430 @default.
• W2092632935 doi "https://doi.org/10.1053/j.ackd.2009.08.008" @default.
• W2092632935 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19801139" @default.
• W2092632935 hasPublicationYear "2009" @default.
• W2092632935 type Work @default.
• W2092632935 sameAs 2092632935 @default.
• W2092632935 citedByCount "7" @default.
• W2092632935 countsByYear W20926329352013 @default.
• W2092632935 countsByYear W20926329352014 @default.
• W2092632935 countsByYear W20926329352019 @default.
• W2092632935 crossrefType "journal-article" @default.
• W2092632935 hasAuthorship W2092632935A5068496436 @default.
• W2092632935 hasConcept C1008401 @default.
• W2092632935 hasConcept C126322002 @default.
• W2092632935 hasConcept C141071460 @default.
• W2092632935 hasConcept C1862650 @default.
• W2092632935 hasConcept C2776263037 @default.
• W2092632935 hasConcept C2776418732 @default.
• W2092632935 hasConcept C2779764123 @default.
• W2092632935 hasConcept C2779959927 @default.
• W2092632935 hasConcept C2780247198 @default.
• W2092632935 hasConcept C2781172350 @default.
• W2092632935 hasConcept C71924100 @default.
• W2092632935 hasConcept C99508421 @default.
• W2092632935 hasConcept C99830354 @default.
• W2092632935 hasConceptScore W2092632935C1008401 @default.
• W2092632935 hasConceptScore W2092632935C126322002 @default.
• W2092632935 hasConceptScore W2092632935C141071460 @default.
• W2092632935 hasConceptScore W2092632935C1862650 @default.
• W2092632935 hasConceptScore W2092632935C2776263037 @default.
• W2092632935 hasConceptScore W2092632935C2776418732 @default.
• W2092632935 hasConceptScore W2092632935C2779764123 @default.
• W2092632935 hasConceptScore W2092632935C2779959927 @default.
• W2092632935 hasConceptScore W2092632935C2780247198 @default.
• W2092632935 hasConceptScore W2092632935C2781172350 @default.
• W2092632935 hasConceptScore W2092632935C71924100 @default.
• W2092632935 hasConceptScore W2092632935C99508421 @default.
• W2092632935 hasConceptScore W2092632935C99830354 @default.
• W2092632935 hasIssue "6" @default.

• next